Voltammetric DNA biosensor for the study of mechanism of action of anticancer drug-adriamycin

被引:0
|
作者
Tiwari, Sweety [1 ]
Pitre, K. S. [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Sagar 470003, India
关键词
Modified electrode; Biosensor; Adriamycin; Anthracycline compound;
D O I
暂无
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The interaction of anticancer drug adr amycin with DNA has been studied using voltammetric DNA biosensor. The binding mechanism of adriamycin was elucidated by using differential pulse voltammetry (DPV) at DNA modified glassy carbon fiber electrodes (GCFE). The decrease in guanine oxidation peak current at +0.9 V was used as an indicator for interaction mechanism in acetate buffer (pH 4.5). The studied drug-DNA interaction mechanism at charged electrode surface is similar to the in-vivo DNA-drug complex formation, where DNA is in close contact with charged phospholipid membranes and proteins. Thus, the fabricated biosensor helps in understanding the in-vivo mechanism of action of this anticancer drug.
引用
收藏
页码:593 / 597
页数:5
相关论文
共 50 条
  • [31] DNA topoisomerase II as the target for the anticancer drug TOP-53: Mechanistic basis for drug action
    Byl, JAW
    Cline, SD
    Utsugi, T
    Kobunai, T
    Yamada, Y
    Osheroff, N
    BIOCHEMISTRY, 2001, 40 (03) : 712 - 718
  • [32] A Label-Free DNA Biosensor for Determination of Topotecan as an Anticancer Drug: Electrochemical, Spectroscopic and Docking Studies
    Akbari Javar, Hamid
    Mahmoudi-Moghaddam, Hadi
    JOURNAL OF THE ELECTROCHEMICAL SOCIETY, 2020, 167 (12)
  • [33] A New Mechanism of Action for the Anticancer Drug Mitomycin C: Mechanism-Based Inhibition of Thioredoxin Reductase
    Paz, Manuel M.
    Zhang, Xu
    Lu, Jun
    Holmgren, Arne
    CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (07) : 1502 - 1511
  • [34] Theoretical Study on Interactions Between Berberine as an Anticancer Drug and DNA
    Jadid, A. Parchehbaf
    Zarefatin, Leila
    Javadi, Leila
    ASIAN JOURNAL OF CHEMISTRY, 2013, 25 (05) : 2615 - 2621
  • [35] A spectroscopic study on the DNA binding behavior of the anticancer drug dacarbazine
    Wang, XM
    Li, Y
    Gong, SJ
    Fu, DA
    SPECTROSCOPY LETTERS, 2002, 35 (06) : 751 - 756
  • [36] Elucidating the mechanism of action of titanium(IV) complexes for a new anticancer drug design strategy
    Perez, Sofia
    Akam, Eman
    Gaur, Kavita
    Delgado, Yamixa
    Tomat, Elisa
    Tinoco, Arthur
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [37] DNA TOPOISOMERASE-II ISOZYMES INVOLVED IN ANTICANCER DRUG-ACTION AND RESISTANCE
    FERNANDES, DJ
    QIU, J
    CATAPANO, CV
    ADVANCES IN ENZYME REGULATION, VOL 35, 1995, 35 : 265 - 281
  • [38] Study suggests green tea blocks action of anticancer drug bortezomib
    不详
    FUTURE ONCOLOGY, 2009, 5 (03) : 288 - 288
  • [39] Considerations concerning design and mechanism of action of a new class of anticancer dual DNA intercalators
    Luca, Mihaela Catalina C.
    Tura, Vasile V.
    Mangalagiu, Ionel I.
    MEDICAL HYPOTHESES, 2010, 75 (06) : 627 - 629
  • [40] A theoretical study on interactions between mitoxantrone as an anticancer drug and DNA: Application in drug design
    Riahi, Siavash
    Ganjali, Mohammad Reza
    Dinarvand, Rassoul
    Karamdoust, Sanaz
    Bagherzadeh, Kowsar
    Norouzi, Parviz
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (05) : 474 - 482